These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 16381242)

  • 1. [Retreatment of patients with chronic hepatitis C].
    Ostojić R
    Acta Med Croatica; 2005; 59(5):447-51. PubMed ID: 16381242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the treatment of hepatitis C.
    Lawrence SP
    Adv Intern Med; 2000; 45():65-105. PubMed ID: 10635046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retreatment of patients with chronic hepatitis C.
    Shiffman ML
    Hepatology; 2002 Nov; 36(5 Suppl 1):S128-34. PubMed ID: 12407586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic hepatitis C and no response to antiviral therapy: potential current and future therapeutic options.
    Papatheodoridis GV; Cholongitas E
    J Viral Hepat; 2004 Jul; 11(4):287-96. PubMed ID: 15230850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
    Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A
    Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatitis C virus infection in patients with end-stage renal disease.
    Liu CH; Kao JH
    J Gastroenterol Hepatol; 2011 Feb; 26(2):228-39. PubMed ID: 21261711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of selected clinical factors as predictors of response to combined interferon-alpha plus ribavirin therapy among patients with chronic hepatitis C.
    Kryczka W; Zarebska-Michaluk D; Chrapek M
    Med Sci Monit; 2003 Aug; 9 Suppl 3():32-5. PubMed ID: 15156609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of pegylated interferon beta-1a therapy on the liver fibrosis in chronic hepatitis C: a semi-quantitative analysis].
    Rao HY; Li J; Zhang LF; Chen HY; Zhu LM; Wei L; Sun Y; Wang H
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):96-100. PubMed ID: 18353212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic hepatitis C: retreatment of relapsers. An evidence-based approach.
    Cammà C; Craxì A
    Semin Gastrointest Dis; 2000 Apr; 11(2):115-21. PubMed ID: 10803635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
    Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
    Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retreating chronic hepatitis C with daily interferon alfacon-1/ribavirin after nonresponse to pegylated interferon/ribavirin: DIRECT results.
    Bacon BR; Shiffman ML; Mendes F; Ghalib R; Hassanein T; Morelli G; Joshi S; Rothstein K; Kwo P; Gitlin N
    Hepatology; 2009 Jun; 49(6):1838-46. PubMed ID: 19291790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficacy of combined antiviral therapy with interferon alfa and ribavirin in chronic hepatitis C patients with extrahepatic manifestations].
    Zarebska-Michaluk D; Lebensztejn DM; Kryczka W
    Przegl Epidemiol; 2007; 61(3):551-8. PubMed ID: 18069393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and immunologic impact of using interferon and ribavirin in the immunosuppressed host.
    Braun M; Vierling JM
    Liver Transpl; 2003 Nov; 9(11):S79-89. PubMed ID: 14586901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Successful treatment of chronic hepatitis C in hemophiliacs based on historical development of therapeutic protocols].
    Husa P; Smejkal P; Husová L; Chalupa P; Penka M
    Vnitr Lek; 2004 Jan; 50(1):30-5. PubMed ID: 15015227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retreatment of chronic hepatitis C virus infection in patients who failed to achieve sustained virologic response.
    Shiffman ML
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):37-49. PubMed ID: 15719005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus antiviral therapy in patients with cirrhosis.
    Arenas JI; Vargas HE
    Gastroenterol Clin North Am; 2004 Sep; 33(3):549-62, ix. PubMed ID: 15324943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral therapy: why does it fail in HCV-related chronic hepatitis?
    Masarone M; Persico M
    Expert Rev Anti Infect Ther; 2011 May; 9(5):535-43. PubMed ID: 21609265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of chronic hepatitis C virus infection with interferon alfa and ribavirin: sustained response in two patients with transfusion dependent thalassaemia.
    Hamidah A; Yong JF; Zulkifli HI; Jamal R
    Med J Malaysia; 2002 Sep; 57(3):353-6. PubMed ID: 12440276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of nonresponsive hepatitis C.
    Bailly F; Ahmed SN; Pradat P; Trepo C
    Expert Rev Anti Infect Ther; 2010 Apr; 8(4):379-95. PubMed ID: 20377334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and prevention of hepatitis C].
    Poynard T; Ratziu V; Benhamou Y; Regimbeau C
    Rev Prat; 2000 May; 50(10):1100-7. PubMed ID: 10905096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.